Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

3.08
Delayed Data
As of Aug 26
 +0.01 / +0.33%
Today’s Change
1.24
Today|||52-Week Range
3.46
+62.96%
Year-to-Date
No recent news for Amarin Corporation PLC.

Today’s Trading

Previous close3.07
Today’s open3.08
Day’s range3.01 - 3.10
Volume2,673,362
Average volume (3 months)2,150,567
Market cap$633.4M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+17.86%
Earnings growth (next 5 years)+207.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...+0.32+2.24%
ARWRArrowhead Pharmaceut...+0.07+1.02%
RGNXRegenxbio Inc-0.08-0.64%
BSTCBiospecifics Technol...+0.54+1.48%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
Senior VP, Chief Financial &
Accounting Officer
Michael W. Kalb
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs